S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 129.4 SEK 0.7%
Market Cap: 6.6B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Surgical Science Sweden AB
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Surgical Science Sweden AB
Cost of Revenue Peer Comparison

Comparables:
EKTA B
CEVI
GETI B
ARJO B
S
STIL

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
S
Surgical Science Sweden AB
STO:SUS
Cost of Revenue
-kr264m
CAGR 3-Years
-130%
CAGR 5-Years
-73%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cost of Revenue
-kr11.3B
CAGR 3-Years
-12%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cost of Revenue
-kr242.4m
CAGR 3-Years
-15%
CAGR 5-Years
-19%
CAGR 10-Years
-12%
Getinge AB
STO:GETI B
Cost of Revenue
-kr17.3B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cost of Revenue
-kr6.2B
CAGR 3-Years
-8%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Cost of Revenue
-kr223.6m
CAGR 3-Years
-38%
CAGR 5-Years
-22%
CAGR 10-Years
-15%

See Also

What is Surgical Science Sweden AB's Cost of Revenue?
Cost of Revenue
-264m SEK

Based on the financial report for Jun 30, 2024, Surgical Science Sweden AB's Cost of Revenue amounts to -264m SEK.

What is Surgical Science Sweden AB's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-73%

Over the last year, the Cost of Revenue growth was 10%. The average annual Cost of Revenue growth rates for Surgical Science Sweden AB have been -130% over the past three years , -73% over the past five years .

Back to Top